eCysticFibrosis Review
By eCysticFibrosis Review
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by eCysticFibrosis Review
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 73
Description
Expert insight and analysis providing information directly relevant to cystic fibrosis care, through topic-focused newsletters summarizing the peer-reviewed literature and accompanying podcasts to illustrate how to apply that information in the clinic.
Hosted on Acast. See acast.com/privacy for more information.
| Episode | Date |
|---|---|
|
Cystic Fibrosis Life Transitions
|
Jul 03, 2025 |
|
CF and Diet and Nutrition: The Changing Paradigm
|
Dec 23, 2022 |
|
ETI (CFTR Triple Therapy): Clinical Opportunities
|
Sep 14, 2022 |
|
Pulmonary Exacerbations and IV Antibiotics
|
Jul 20, 2022 |
|
Race, Ethnicity, and Cystic Fibrosis
|
Jun 21, 2022 |
|
The Pancreas, Malnutrition, and CFTR Modulators
|
Mar 23, 2021 |
|
CF and COVID-19: The Data and the Real World
|
Dec 17, 2020 |
|
Overcoming Shutdown Challenges
|
Dec 07, 2020 |
|
Managing Psychosocial and Economic Stress
|
Dec 07, 2020 |
|
Maintaining CF Infection Prevention and Control
|
Dec 07, 2020 |
|
Clinical Considerations for Women with CF
|
Nov 28, 2020 |
|
Antibiotics, Dosing, and CFTR
|
Sep 30, 2020 |
|
Bringing Telemedicine to the CF Clinic: A Success Story
|
Sep 02, 2020 |
|
CFTR, Growth & Liver Disease: A Clinical Perspective
|
Aug 03, 2020 |
|
In the Clinic: Triple Combination CFTR Modulation
|
Jun 02, 2020 |
|
Addressing Mental Health in CF
|
May 05, 2020 |
|
Clinical Considerations: New Anti-Inflammatories & New CFTR Modulators
|
Oct 11, 2019 |
|
Continuous Alternating Therapies: A Clinical Perspective
|
Aug 10, 2019 |
|
In The Clinic: CFTR Modification & Nutritional Deficiencies
|
Jun 21, 2019 |
|
NTM Infection: Today's Treatments & New Antibiotics in Development
|
May 07, 2019 |
|
NTM Infection: Risk of Patient-to-Patient Transmission in CF Centers
|
May 07, 2019 |
|
NTM Infection: Risks of Acquisition from the Environment
|
May 07, 2019 |
|
Clinical Insight: CFTR Modulators
|
Mar 08, 2019 |
|
Clinical Approaches to MDR Lung Infections
|
Jan 18, 2019 |
|
Lung Transplant and CRC Screening
|
Oct 26, 2018 |
|
CFTR Modulators: Clinical Insights
|
Feb 03, 2018 |
|
Screening and Diagnosis of CFRD
|
Oct 27, 2017 |
|
New Directions in CFTR Modification
|
Sep 08, 2017 |
|
Nutritional Management for Individuals with CF: Practical Applications
|
Jun 28, 2017 |
|
Adherence – What You Should be Telling Your Patients
|
Apr 25, 2017 |
|
Weighing the Options in Managing Exacerbations
|
Feb 28, 2017 |
|
Future Landscape of CFTR Modulators
|
Nov 17, 2016 |
|
Pseudomonas aeruginosa Eradication and Outcomes: Key Questions
|
Sep 15, 2016 |
|
Nutritional Issues in Cystic Fibrosis
|
Jul 14, 2016 |
|
Trends in Inhaled Antibiotic Therapy
|
May 17, 2016 |
|
Pulmonary Exacerbations and the Microbiology of the CF Lung
|
Mar 30, 2016 |
|
The Current State of CFTR Modification
|
Jan 28, 2016 |
|
Breaking Coverage of CAT trial
|
Dec 22, 2015 |
|
Breaking Coverage of CAT trial
|
Dec 22, 2015 |
|
Breaking Coverage of CAT trial
|
Dec 22, 2015 |
|
Breaking Coverage of CAT trial
|
Dec 22, 2015 |
|
Agents for the management of Pseudomonas aeruginosa infection
|
Nov 19, 2015 |
|
Benefits of CFTR Modification Beyond FEV1 Improvement
|
Sep 30, 2015 |
|
The Effects of CFTR-modifying Therapies
|
Aug 20, 2015 |
|
Optimizing Nutrition in Individuals with Cystic Fibrosis
|
Jun 23, 2015 |
|
Improving digestive capabilities in nutritionally compromised patients with CF
|
Apr 16, 2015 |
|
P. aeruginosa eradication and reinfection
|
Feb 26, 2015 |
|
Pulmonary exacerbations: diagnoses, and therapeutic regimens
|
Dec 26, 2014 |
|
What Does CFTR Tell Us About Lung Disease?
|
Apr 08, 2014 |
|
Behavioral Treatment to Improve Dietary Adherence and Weight Gain in Children with Cystic Fibrosis
|
Feb 11, 2014 |
|
Highlights of the 27th Annual North American Cystic Fibrosis Conference
|
Jan 08, 2014 |
|
Special Edition 2014 - Steven Rowe: Highlights of the 27th Annual North American Cystic Fibrosis Conference
|
Jan 08, 2014 |
|
Highlights of the 27th Annual North American Cystic Fibrosis Conference
|
Jan 08, 2014 |
|
Highlights of the 27th Annual North American Cystic Fibrosis Conference
|
Jan 08, 2014 |
|
Highlights of the 27th Annual North American Cystic Fibrosis Conference
|
Jan 08, 2014 |
|
New Therapies in Cystic Fibrosis Directed Toward the Basic Defect
|
Nov 26, 2013 |
|
P. aeruginosa Eradication
|
Jul 30, 2013 |
|
Strategies for the Improvement of Nutrition Outcomes
|
May 29, 2013 |
|
Adherence to Chronic Inhaled Therapies
|
Mar 28, 2013 |
|
Featured Cases: Emerging Pathogens in Cystic Fibrosis
|
Jul 23, 2012 |
|
Featured Cases: The Role of Exercise and Physical Activity in Optimizing Outcomes Among Patients with CF
|
May 22, 2012 |
|
Featured Cases: Interventions to Improve Nutrition in Patients with CF
|
Mar 20, 2012 |
|
Featured Cases: Modifiers of CF Lung Disease
|
Jan 17, 2012 |
|
Featured Cases: Exacerbation Therapies
|
Nov 18, 2011 |
|
Featured Cases: New Inhalation Therapies
|
Dec 02, 2010 |
|
Featured Cases: State-of-the-Art Treatment for CF Lung Disease
|
Sep 14, 2010 |
|
Featured Cases: Vitamin D and Bone Health
|
Jul 13, 2010 |
|
Featured Cases: Nutritional Challenges and Complications in Patients with CF
|
May 13, 2010 |
|
Featured Cases: Allergic Bronchopulmonary Aspergillosis (ABPA)
|
Mar 09, 2010 |
|
Featured Cases: Cystic Fibrosis–Related Diabetes
|
Jan 12, 2010 |
|
Measurement of Early Lung Disease in Children With Cystic Fibrosis
|
Jan 15, 2009 |
|
Emerging Pathogens in Cystic Fibrosis
|
Nov 13, 2008 |
|
How to Interpret Genetic Tests for Cystic Fibrosis
|
Sep 18, 2008 |